Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Ethex recalls 30mg and 60mg Morphine sulfate tablets
Oversized tablets may contain as much as two times the labeled level of active morphine sulfate. The recalled lots were distributed by Ethex under an ‘Ethex’ label between
Oversized tablets may contain as much as two times the labeled level of active morphine sulfate. The recalled lots were distributed by Ethex under an ‘Ethex’ label between
The Digest efficacy trial tested a one capsule per-meal dosing regimen and will study fat, protein and carbohydrate absorption in cystic fibrosis patients with exocrine pancreatic insufficiency. In
As a result of the partnership, American Tissue Services Foundation (ATSF) will offer families the opportunity to donate peripheral nerves. Peripheral nerves facilitate communication of signals between the
As a result of the closing, the company will issue 5.77 million shares of common stock and warrants to acquire 5.77 million shares of common stock at an
As a result of this regulatory progress, the company and Nordic Biotech Venture Fund II (Nordic) have amended their joint venture agreement for the development and commercialization of
The company presented the data in a subset of 26 patients with high-risk myelodysplastic syndromes (MDS) by French-American-British Group criteria. The median age of the patients in the
Approximately 17 subjects have received at least one dose of XL228, of whom 16 had completed cycle 1. The trial is evaluating a treatment cycle consisting of four
The Phase II data indicated that Arikace, delivered once daily for 28 consecutive days, produced a significant improvement in lung function, was well-tolerated, and had a side-effect profile
Emergency Filtration Products’s (EFP) NanoMask is a surgical mask containing a hydrophobic filter medium coated with NanoFense, a proprietary nano silver antimicrobial formulation developed by EFP’s future merger
SuperGen’s SGI-1776 was identified as an orally available, potent and selective inhibitor of the PIM kinases. SGI-1776 was found to induce cell cycle arrest, dose dependent apoptosis and